ARM (NASDAQ:ARM) Shares Up 13.6% on Earnings Beat

Key Points

• Shares jumped 13.6% intraday after ARM beat estimates (EPS $0.60 vs. $0.58; revenue $1.49B vs. $1.47B), trading as high as $239.50 on ~20.5M shares—about 175% above average volume.
• Bullish momentum and analyst upgrades (Mizuho PT $255) have been driven by ARM's strategic push into in‑house AI/data‑center CPUs and unusual call‑option activity, though execution and partner‑conflict risks remain.
• Insider selling (CEO and CFO recently trimmed positions) and a lofty valuation (market cap ~$250.7B; P/E ~316) signal elevated short‑term volatility despite the positive earnings print.

Shares of ARM Holdings PLC Sponsored ADR (NASDAQ:ARM - Get Free Report) rose 13.6% during mid-day trading on Wednesday following a stronger than expected earnings report. The stock traded as high as $239.50 and last traded at $237.30. Approximately 20,472,451 shares were traded during trading, an increase of 175% from the average daily volume of 7,433,461 shares. The stock had previously closed at $208.84.

The company reported $0.60 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.58 by $0.02. ARM had a return on equity of 14.01% and a net margin of 17.15%.The business had revenue of $1.49 billion during the quarter, compared to analyst estimates of $1.47 billion.

More ARM News

Here are the key news stories impacting ARM this week:

• Positive Sentiment: Sector rally after AMD’s strong forecast lifted chipmakers, giving ARM momentum as investors rotate into AI and CPU plays. AMD forecast sparks AI‑driven rally in US chipmaker stocks
• Positive Sentiment: Mizuho raised its price target to $255 and kept an “outperform” rating, signaling incremental analyst conviction that supports upside. Benzinga
• Positive Sentiment: Unusually large call‑option activity — ~87,690 calls traded (≈+35% vs. typical daily call volume) — indicates speculative bullish positioning ahead of earnings.
• Positive Sentiment: Company is accelerating a strategic shift into in‑house AI/data‑center CPUs (including a first AGI/data‑center CPU and IBM collaboration), which could materially expand addressable market and revenue if executed. How Arm’s First In‑House AI Data Center CPU Could Impact Arm Holdings (ARM) Investors
• Neutral Sentiment: Earnings day acts as the immediate catalyst — results and guidance will likely drive volatility as the market tests whether top‑line and AI traction justify the premium valuation. Arm Is Shifting Its Business Model. Earnings Will Be a Test for the Stock.
• Neutral Sentiment: Market commentary expects a sizable post‑earnings move, increasing short‑term trading risk even if fundamentals remain intact. How Much Is Arm Holdings Stock Expected to Move After Earnings?
• Negative Sentiment: Strategic shift into making proprietary data‑center CPUs could pit ARM against some licensees (customers), creating potential channel conflict and execution/partner risk. Arm Is Shifting Its Business Model. Earnings Will Be a Test for the Stock.
• Negative Sentiment: Technical and market‑commentary warnings suggest a sharp downside is possible if earnings disappoint or guidance is weak. Arm Holdings Stock May Plunge Following Results (Technical Analysis)
• Negative Sentiment: Minor headwind reported: TSMC’s $231M exit note created some headlines, though the move hasn’t stopped buyer interest. Arm shares climb despite TSMC's $231 million exit

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on the stock. HSBC raised shares of ARM from a "reduce" rating to a "buy" rating and lifted their price target for the stock from $90.00 to $205.00 in a research note on Friday, March 20th. Jefferies Financial Group set a $170.00 target price on ARM in a research note on Thursday, February 5th. Evercore cut their price target on ARM from $215.00 to $170.00 and set an "outperform" rating on the stock in a research note on Thursday, February 5th. New Street Research raised ARM from a "neutral" rating to a "buy" rating in a report on Thursday, February 5th. Finally, UBS Group lowered their price objective on ARM from $175.00 to $170.00 and set a "buy" rating for the company in a research note on Thursday, February 5th. Eighteen equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $177.75.

Insider Buying and Selling at ARM

In other ARM news, CFO Jason Child sold 21,280 shares of the firm's stock in a transaction on Wednesday, March 25th. The shares were sold at an average price of $148.37, for a total transaction of $3,157,313.60. Following the completion of the transaction, the chief financial officer directly owned 174,706 shares of the company's stock, valued at $25,921,129.22. This trade represents a 10.86% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Rene A. Haas sold 23,867 shares of the company's stock in a transaction dated Wednesday, March 25th. The shares were sold at an average price of $161.17, for a total transaction of $3,846,644.39. Following the completion of the sale, the chief executive officer owned 290,965 shares in the company, valued at approximately $46,894,829.05. This trade represents a 7.58% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 83,712 shares of company stock valued at $13,614,730.

Institutional Trading of ARM

Institutional investors and hedge funds have recently bought and sold shares of the company. Amundi grew its position in shares of ARM by 24.8% in the 1st quarter. Amundi now owns 11,804 shares of the company's stock worth $1,153,000 after acquiring an additional 2,345 shares in the last quarter. Empowered Funds LLC raised its position in shares of ARM by 28.8% during the 1st quarter. Empowered Funds LLC now owns 4,887 shares of the company's stock valued at $522,000 after acquiring an additional 1,094 shares in the last quarter. Schnieders Capital Management LLC. lifted its stake in ARM by 9.0% during the second quarter. Schnieders Capital Management LLC. now owns 2,430 shares of the company's stock worth $393,000 after purchasing an additional 200 shares during the last quarter. Bank of Nova Scotia acquired a new position in ARM in the second quarter worth $556,000. Finally, State Street Corp boosted its holdings in ARM by 14.7% in the second quarter. State Street Corp now owns 441,445 shares of the company's stock worth $71,399,000 after purchasing an additional 56,656 shares during the period. Institutional investors and hedge funds own 7.53% of the company's stock.

ARM Stock Up 13.6%

The stock has a market cap of $250.71 billion, a P/E ratio of 316.40, a price-to-earnings-growth ratio of 9.16 and a beta of 3.40. The firm's 50 day simple moving average is $150.26 and its two-hundred day simple moving average is $137.61.

ARM Company Profile

Arm Limited NASDAQ: ARM is a global semiconductor IP company best known for designing energy-efficient processor architectures and related technologies that underpin a wide range of computing devices. Founded in 1990 as a joint venture between Acorn Computers, Apple and VLSI Technology and headquartered in Cambridge, England, Arm develops the ARM instruction set architectures and core processor designs that chipmakers license and integrate into custom system-on-chip (SoC) products. The company operates a licensing and royalty business model rather than manufacturing chips itself.

Arm's product portfolio includes CPU core families (such as Cortex and Neoverse lines), GPU and multimedia IP (Mali), neural processing units (Ethos) and a suite of system and physical IP blocks.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.